Empfehlungen zur Malariaprophylaxe

Key words

travel medicine - malaria - repellents - chemoprophylaxis - pediatric travelers - pregnant travelers

Publication History

Article published online:
13 August 2021

• Literatur

• 1 Deutsche Gesellschaft für Tropenmedizin, Reisemedizin und Globale Gesundheit. Leitlinie: Diagnostik und Therapie der Malaria. Version Februar 2021. Im Internet https://www.awmf.org/uploads/tx_szleitlinien/042-001l_S1_Diagnostik-Therapie-Malaria_2021-05.pdf
• 2 World Health Organization World Malaria Report 2020. Geneva: WHO; 2020
• 3 Falkenhorst G, Enkelmann J, Lachmann R. et al Zur Situation bei wichtigen Infektionskrankheiten, reiseassoziierte Krankheiten 2018. Epid Bull 2019; 48: 513-321
• 4 Falkenhorst G. Persönliche Kommunikation. 2021
• 5 Amato R, Pearson RD, Almagro-Garcia J. et al Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis 2018; 18: 337-345
• 6 van der Pluijm RW, Tripura R, Hoglund RM. et al Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. Lancet 2020; 395: 1345-1360
• 7 Schlabe S, Reiter Owona I, Nordmann T. et al Rapid diagnostic test negative Plasmodium falciparum malaria in a traveller returning from Ethiopia. Malar J 2021; 20: 145
• 8 Parr JB, Verity R, Doctor SM. et al Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey. J Infect Dis 2017; 216: 36-44
• 9 Plucinski MM, Herman C, Jones S. et al Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay. J Infect Dis 2019; 219: 437-447
• 10 World Health Organization. WHO Malaria Threats Maps 2021. Im Internet https://eref.thieme.de/UL4BJ
• 11 Fradin MS. Insect Protection. In Keystone J, Kozarsky P, Connor B, Nothdurft H, Mendelson M, Leder K (eds.). ravel Medicine 4th ed. Elsevier; 2019. 43-52
• 12 United States Environmental Protection Agency. DEET. Im Internet www.epa.gov/insect-repellents/deet
• 13 The Medical Letter Inc Insect Repellents. The Medical Letter on Drugs and Therapeutics 2019; 61: Issue 1579
• 14 GOV.UK. Malaria prevention guidelines for travellers from the UK. Last updated 9 June 2021. Im Internet www.gov.uk/government/publications/malaria-prevention-guidelines-for-travellers-from-the-uk
• 15 Stanczyk NM, Behrens RH, Chen-Hussey V. et al Mosquito repellents for travellers. BMJ 2015; 350: h99
• 16 World Health Organization World Malaria Report 2019. Geneva: WHO; 2019
• 17 Lupi E, Hatz C, Schlagenhauf P. The efficacy of repellents against Aedes, Anopheles, Culex and Ixodes spp. – a literature review. Travel Med Infect Dis 2013; 11: 374-411
• 18 Vinnemeier CD, Rothe C, Kreuels B. et al Response to fever and utilization of standby emergency treatment (SBET) for malaria in travellers to Southeast Asia: a questionnaire-based cohort study. Malar J 2017; 16: 44
• 19 Tan R, Elmers J, Genton B. Malaria standby emergency treatment (SBET) for travellers visiting malaria endemic areas: a systematic review and meta-analysis. J Travel Med 2019; 26 pii: taz027
• 20 Ferrara P, Masuet-Aumatell C, Agüero F. et al Stand-by emergency treatment (SBET) of malaria in Spanish travellers: a cohort study. Malar J 2018; 17: 134
• 21 Ferrara P, Masuet-Aumatell C, Agüero F. et al The use of stand-by emergency treatment (SBET) for malaria in travellers: A systematic review and meta-analysis of observational studies. J Infect 2018; 77: 455-462
• 22 Gaillard T, Briolant S, Madamet M. et al The end of a dogma: the safety of doxycycline use in young children for malaria treatment. Malar J 2017; 16: 1488
• 23 Chelapharm. Educational Material Lariam. Im Internet https://www.cheplapharm.com/educational-material/lariam/
• 24 Adamcova M, Schaerer MT, Bercaru I. et al Eye disorders reported with the use of mefloquine (Lariam) chemoprophylaxis – A drug safety database analysis. Travel Med Infect Dis 2015; 13: 400-408
• 25 Fachinformation Lariam, Stand: August 2018. Im Internet https://s3.eu-central-1.amazonaws.com/prod-cerebro-ifap/media_all/93178.pdf
• 26 Chiodini PL, Patel D, Goodyer L, Ranson H. Guidelines for malaria prevention in travellers from the United Kingdom, 2021. London: Public Health England March; 2021: 172
• 27 Chan XHS, Win YN, Mawer LJ. et al Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis. Lancet Infect Dis 2018; 18: 913-923
• 28 Kurth F, Develoux M, Mechain M. et al Severe malaria in Europe: an 8-year multi-centre observational study. Malar J 2017; 16: 578
• 29 Kurth F, Lingscheid T, Steiner F. et al Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria. Emerg Infect Dis 2016; 22: 1381-1386
• 30 Froeschl G, Nothdurft HD, von Sonnenburg F. et al Retrospective clinical case series study in 2017 identifies Plasmodium knowlesi as most frequent Plasmodium species in returning travellers from Thailand to Germany. Euro Surveill. 2018 23.
• 31 Schwartz E, Parise M, Kozarsky P. et al Delayed onset of malaria – implications for chemoprophylaxis in travelers. N Engl J Med 2003; 349: 1510-1516
• 32 Baird JK. Tafenoquine for travelers' malaria: evidence, rationale and recommendations J Travel Med. 2018 25.
• 33 Pays JF. Threats to the Effectiveness of Malaria Treatment. Bull Soc Pathol Exot 2018; 111: 197-198
• 34 Ashley EA, Phyo AP, Woodrow CJ. Malaria. Lancet 2018; 391: 1608-1621
• 35 Grobusch MP, Kremsner PG. Uncomplicated malaria. Curr Top Microbiol Immunol 2005; 295: 83-104
• 36 Wilson ME, Weld LH, Boggild A. et al Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis 2007; 44: 1560-1568
• 37 Froeschl G, Beissner M, Huber K. et al Plasmodium knowlesi infection in a returning German traveller from Thailand: a case report on an emerging malaria pathogen in a popular low-risk travel destination. BMC Infect Dis 2018; 18: 1488
• 38 Albright TA, Binns HJ, Katz BZ. Side effects of and compliance with malaria prophylaxis in children. J Travel Med 2002; 9: 289-292
• 39 Emryotox.de. Doxycyclin. Im Internet: https://www.embryotox.de/arzneimittel/details/doxycyclin/
• 40 HIV Drug interactions. Im Internet www.hiv-druginteractions.org
• 41 Infrastruktur BfVud (ed.). Seeärztlicher Dienst DSBV Malaria-Merkblatt: Hamburg; 2018. 8.
• 42 World Health Organization. International Medical Guide for Ships. 3^rd ed. 2007. Im Internet https://apps.who.int/iris/bitstream/handle/10665/43814/9789240682313_eng.pdf?sequence=1">https://apps.who.int/iris/bitstream/handle/10665/43814/9789240682313_eng.pdf?sequence=1
• 43 von Seidlein L. The Advanced Development Pathway of the RTS,S/AS01 Vaccine. Methods Mol Biol 2019; 2013: 177-187
• 44 Adepoju P. RTS,S malaria vaccine pilots in three African countries. Lancet 2019; 393: 16858
• 45 Mordmuller B, Supan C, Sim KL. et al Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Malar J 2015; 14: 1178
• 46 Mordmuller B, Surat G, Lagler H. et al Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature 2017; 542: 445-449
• 47 Lyke KE, Ishizuka AS, Berry AA. et al Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc Natl Acad Sci U S A 2017; 114: 2711-2716
• 48 Mordmuller B, Sulyok M, Egger-Adam D. et al First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria. Clin Infect Dis 2019; 69: 1509-1516
• 49 Metzger WG, Sulyok Z, Theurer A. et al [Development of malaria vaccines-state of the art]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020; 63: 45-55
• 50 Schlagenhauf P, Wilson ME, Petersen E, MbCarthy A, Chen LH. Malaria Chemoprophylaxis. In Keystone J, Kozarsky P, Connor B, Nothdurft H, Mendelson M, Leder K(eds.). Travel Medicine 4th ed. Elsevier; 2019. 145-167
• 51 Bundesamt für Gesundheit (BAG) und Expertenkomitee für Reisemedizin (EKRM). Maalariaschutz für Kurzzeitaufenthalter (Reisen bis zu 3 Monaten) BAG Januar. 2016 24.